Literature DB >> 19889762

Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.

Mathieu Mateo1, St Patrick Reid, Lawrence W Leung, Christopher F Basler, Viktor E Volchkov.   

Abstract

The Ebolavirus VP24 protein counteracts alpha/beta interferon (IFN-alpha/beta) and IFN-gamma signaling by blocking the nuclear accumulation of tyrosine-phosphorylated STAT1 (PY-STAT1). According to the proposed model, VP24 binding to members of the NPI-1 subfamily of karyopherin alpha (KPNalpha) nuclear localization signal receptors prevents their binding to PY-STAT1, thereby preventing PY-STAT1 nuclear accumulation. This study now identifies two domains of VP24 required for inhibition of IFN-beta-induced gene expression and PY-STAT1 nuclear accumulation. We demonstrate that loss of function correlates with loss of binding to KPNalpha proteins. Thus, the VP24 IFN antagonist function requires the ability of VP24 to interact with KPNalpha.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889762      PMCID: PMC2798383          DOI: 10.1128/JVI.01372-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.

Authors:  B H Harcourt; A Sanchez; M K Offermann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Regulation of Stat3 nuclear import by importin alpha5 and importin alpha7 via two different functional sequence elements.

Authors:  Jing Ma; Xinmin Cao
Journal:  Cell Signal       Date:  2005-11-18       Impact factor: 4.315

3.  Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.

Authors:  John C Kash; Elke Mühlberger; Victoria Carter; Melanie Grosch; Olivia Perwitasari; Sean C Proll; Matthew J Thomas; Friedemann Weber; Hans-Dieter Klenk; Michael G Katze
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Filoviridae: a taxonomic home for Marburg and Ebola viruses?

Authors:  M P Kiley; E T Bowen; G A Eddy; M Isaäcson; K M Johnson; J B McCormick; F A Murphy; S R Pattyn; D Peters; O W Prozesky; R L Regnery; D I Simpson; W Slenczka; P Sureau; G van der Groen; P A Webb; H Wulff
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

5.  Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1.

Authors:  T Sekimoto; N Imamoto; K Nakajima; T Hirano; Y Yoneda
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

6.  Nuclear export determines the cytokine sensitivity of STAT transcription factors.

Authors:  Inga Lödige; Andreas Marg; Burkhard Wiesner; Barbora Malecová; Thomas Oelgeschläger; Uwe Vinkemeier
Journal:  J Biol Chem       Date:  2005-09-28       Impact factor: 5.157

7.  Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5.

Authors:  Riku Fagerlund; Krister Mélen; Leena Kinnunen; Ilkka Julkunen
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

8.  Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells.

Authors:  B H Harcourt; A Sanchez; M K Offermann
Journal:  Virology       Date:  1998-12-05       Impact factor: 3.616

Review 9.  Pathogenesis of filoviral haemorrhagic fevers.

Authors:  Siddhartha Mahanty; Mike Bray
Journal:  Lancet Infect Dis       Date:  2004-08       Impact factor: 25.071

10.  The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

Authors:  Christopher F Basler; Andrea Mikulasova; Luis Martinez-Sobrido; Jason Paragas; Elke Mühlberger; Mike Bray; Hans-Dieter Klenk; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  65 in total

1.  Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.

Authors:  Megan R Edwards; Gai Liu; Chad E Mire; Suhas Sureshchandra; Priya Luthra; Benjamin Yen; Reed S Shabman; Daisy W Leung; Ilhem Messaoudi; Thomas W Geisbert; Gaya K Amarasinghe; Christopher F Basler
Journal:  Cell Rep       Date:  2016-02-11       Impact factor: 9.423

Review 2.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

3.  Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.

Authors:  Tsuyoshi Miyake; Charlotte M Farley; Benjamin E Neubauer; Thomas P Beddow; Thomas Hoenen; Daniel A Engel
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

4.  Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.

Authors:  Philipp A Ilinykh; Ndongala M Lubaki; Steven G Widen; Lynnsey A Renn; Terence C Theisen; Ronald L Rabin; Thomas G Wood; Alexander Bukreyev
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

5.  The ebolavirus VP24 interferon antagonist: know your enemy.

Authors:  Adrianna P P Zhang; Dafna M Abelson; Zachary A Bornholdt; Tong Liu; Virgil L Woods; Erica Ollmann Saphire
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

6.  Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.

Authors:  Caroline G Williams; Joyce Sweeney Gibbons; Timothy R Keiffer; Priya Luthra; Megan R Edwards; Christopher F Basler
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

7.  Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.

Authors:  Priya Luthra; Jacinth Naidoo; Colette A Pietzsch; Sampriti De; Sudip Khadka; Manu Anantpadma; Caroline G Williams; Megan R Edwards; Robert A Davey; Alexander Bukreyev; Joseph M Ready; Christopher F Basler
Journal:  Antiviral Res       Date:  2018-08-23       Impact factor: 5.970

8.  Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

Authors:  Andrea Rivera; Ilhem Messaoudi
Journal:  ACS Infect Dis       Date:  2015-03-30       Impact factor: 5.084

9.  The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.

Authors:  Ndongala M Lubaki; Philipp Ilinykh; Colette Pietzsch; Bersabeh Tigabu; Alexander N Freiberg; Richard A Koup; Alexander Bukreyev
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.

Authors:  Ari Watt; Felicien Moukambi; Logan Banadyga; Allison Groseth; Julie Callison; Astrid Herwig; Hideki Ebihara; Heinz Feldmann; Thomas Hoenen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.